 |
|
|
|
 |
|
|
Diloxanide furoate
Diloxanide furoate is an anti-protozoal drug used in the treatment of Entamoeba histolytica and some other protozoal infections.
Safety and Effectiveness
A 13-year study conducted by the United States Center for Disease Control between 1977 and 1990 found that this drug had a low incidence of side effects and was successful in treatment of 86% of asymptomatic carriers of Entamoeba histolytica. [1]
Availability by Country
United States: Not currently approved for use. A CDC study authorized the use of this drug in the treatment of 4,371 cases of Entamoeba histolytica from 1977 to 1990. [1]
References
- ^ a b McAuley JB, Herwaldt BL, Stokes SL, et al (1992). "Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States". Clin. Infect. Dis. 15 (3): 464–8. PMID 1520794.
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Diloxanide_furoate". A list of authors is available in Wikipedia.
|
|
|
|
|
|
Top